期刊文献+

可溶型白细胞介素-13受体α2对成纤维细胞胶原蛋白合成的抑制作用

Inhibitory Effect of Soluble IL-13 Receptor Alpha 2 on Fibroblast Collagen Synthesis
下载PDF
导出
摘要 目的应用可溶型IL-13受体α2(sIL-13Rα2)抑制成纤维细胞胶原合成,探索生物治疗纤维化的新途径。方法构建pMSCV/sIL-13Rα2载体和表达sIL-13Rα2的细胞模型,分子量(0.2×106)滤膜离心浓缩培养液,Ni2亲和层析,SDS-PAGE分析sIL-13Rα2,Western blot检测sIL-13Rα2,RT-PCR和羟脯氨酸法显示成纤维细胞Ⅰ型胶原蛋白的表达。结果构建的重组体pMSCV/sIL-13Rα2成功转染入HEK293细胞,并表达sIL-13Rα2。50μg.L-1 IL-13促进人瘢痕成纤维细胞系CRL-1762生成Ⅰ型胶原蛋白,50μmol.L-1 sIL-13Rα2能有效抑制IL-13刺激CRL-1762细胞合成Ⅰ型胶原蛋白。结论 sIL-13Rα2靶向IL-13抑制成纤维细胞Ⅰ型胶原蛋白的合成。 Objective To explore a new biological therapy in fibrosis through inhibiting fibroblast collagen synthesis by soluble IL-13 receptor α 2(sIL-13Rα2).Methods The pMSCV/sIL-13 Rα2 vector was constructed and cell model expressing sIL-13 Rα2 was established.The medium was concentrated by ultrafiltration(0.2×106-molecular-weigh out off) and sIL-13 Rα2 was analyzed by Ni2 affinity chromatography,SDS-PAGE and Western blot.The expression of type Ⅰ collagen protein in fibroblasts was detected by RT-PCR and hydroxyproline method.Results HEK293 cells were successfully transfected with the constructed recombinant pMSCV/sIL-13 Rα2 and expressed sIL-13 Rα2.Type Ⅰ collagen synthesis was promoted by 50 μg·L-1 IL-13 in scar fibroblast CRL-1762 cells.But the promoting effect of IL-13 was inhibited by 50 μmol·L-1 sIL-13 Rα2.Conclusion Type Ⅰ collagen synthesis can be inhibited by targeting IL-13 with sIL-13 Rα2.in fibroblasts.
出处 《南昌大学学报(医学版)》 CAS 2012年第1期1-5,共5页 Journal of Nanchang University:Medical Sciences
基金 国家自然科学基金(30860118)
关键词 成纤维细胞 白细胞介素13受体 Ⅰ型胶原蛋白 fibroblasts interleukin-13 receptor type Ⅰ collagen
  • 相关文献

参考文献13

  • 1Bhogal R K,Stoica C M,McGaha T L. Molecular aspects of regulation of collagen gene expression in fibrosis[J].Journal of Clinical Immunology,2005,(06):592-603.doi:10.1007/s10875-005-7827-3.
  • 2Keane M P,Gomperts B M,Wergt S. IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome[J].Journal of Immunology,2007,(01):511-519.
  • 3Fuschiotti P. Role of IL-13 in systemic sclerosis[J].Cytokine,2011,(03):544-549.doi:10.1016/j.cyto.2011.08.030.
  • 4Lupardus P J,Birnbaum M E,Garcia K C. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Rα2[J].Structures,2010,(03):332-342.
  • 5Chen W,Umasundari S,Yasuhiro T. IL-13Rα2 Membrane and soluble isoforms differ in humansand mice[J].Journal of Immunology,2009.7870-7876.
  • 6Khodoun M,Lewis C C,Yang J Q. Differences in expression,affinity,and function of soluble (s)IL-4R alpha and sIL-13R alpha2 suggest opposite effects on allergic responses[J].Journal of Immunology,2007.6429-6438.
  • 7Townley R G,Sapkota M,Sapkota K. IL-13 and its genetic variants:effect on current asthma treatments[J].Discov Med,2011,(67):513-523.
  • 8Grencis R K,Bancroft A J. Interleukin-13:A key mediator in resistance to gastrointestinal-dwellingnematode parasites[J].Clinical Reviews in Allergy & Immunology,2004,(01):51-60.doi:10.1385/CRIAI:26:1:51.
  • 9Finkelman F D,Shea Donohue T,Morris S C. Interleukin4-and interleukin-13-mediatedhost protection against intestinal nematode parasites[J].Immunological Reviews,2004,(0):139-155.doi:10.1111/j.0105-2896.2004.00192.x.
  • 10Jiang H,Harris M B,Rothman P. IL-4/IL-13 signaling beyond JAK/STAT[J].Allergy and Clinical Immunology International,2000,(06):1063-1070.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部